Advanced search
Publication Cover
Scandinavian Journal of Infectious Diseases Volume 41, 2009 - Issue 6-7
Submit an article Journal homepage
1,107
Views
18
CrossRef citations to date
0
Altmetric
Review Article

Treatment of hepatitis C virus infection: Updated Swedish Consensus recommendations

Martin Lagging From the Department of Infectious Diseases and Virology, Sahlgrenska University Hospital, GöteborgCorrespondence[email protected]
,
Rune Wejstål From the Department of Infectious Diseases and Virology, Sahlgrenska University Hospital, Göteborg; Swedish Reference Group for Antiviral Therapy (RAV)
,
Ingrid Uhnoo Medical Products Agency, Uppsala
,
Barbro Gerdén Medical Products Agency, Uppsala
,
Björn Fischler Departments of Paediatrics
,
Styrbjörn Friman Department of Transplantation and Liver Surgery, Sahlgrenska University Hospital, Göteborg
,
Filip Josephson Clinical Pharmacology
,
Olle Karlström Infectious Diseases, Karolinska University Hospital, Stockholm
,
Per Sangfelt Department of Infectious Diseases and Gastroenterology, University Hospital, Uppsala, Sweden
,
Robert Schvarz Infectious Diseases, Karolinska University Hospital, Stockholm
,
Ola Weiland Infectious Diseases, Karolinska University Hospital, Stockholm
,
For The Swedish Consensus Group From the Department of Infectious Diseases and Virology, Sahlgrenska University Hospital, Göteborg
,
Martin Lagging From the Department of Infectious Diseases and Virology, Sahlgrenska University Hospital, GöteborgCorrespondence[email protected]
,
Rune Wejstål From the Department of Infectious Diseases and Virology, Sahlgrenska University Hospital, Göteborg; Swedish Reference Group for Antiviral Therapy (RAV)
,
Ingrid Uhnoo Medical Products Agency, Uppsala
,
Barbro Gerdén Medical Products Agency, Uppsala
,
Björn Fischler Departments of Paediatrics
,
Styrbjörn Friman Department of Transplantation and Liver Surgery, Sahlgrenska University Hospital, Göteborg
,
Filip Josephson Clinical Pharmacology
,
Olle Karlström Infectious Diseases, Karolinska University Hospital, Stockholm
,
Per Sangfelt Department of Infectious Diseases and Gastroenterology, University Hospital, Uppsala, Sweden
,
Robert Schvarz Infectious Diseases, Karolinska University Hospital, Stockholm
,
Ola Weiland Infectious Diseases, Karolinska University Hospital, Stockholm
&
For The Swedish Consensus Group From the Department of Infectious Diseases and Virology, Sahlgrenska University Hospital, Göteborg
 show all
Pages 389-402 | Received 30 Mar 2009, Published online: 21 Jul 2009

Citations (18)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Malin Ackefors, Maria Castedal, Olav Dahlgard, Hans Verbaan, Henrik Gjertsen, Annika Wernerson & Ola Weiland. (2015) Peg-IFN and ribavirin treatment for recurrence of genotype 2 and 3 hepatitis C after liver transplantation. Infectious Diseases 47:4, pages 209-217.
Read now
Ann-Sofi Duberg, Sarah Blach, Karolin Falconer, Martin Kåberg, Homie Razavi & Soo Aleman. (2015) The future disease burden of hepatitis C virus infection in Sweden and the impact of different treatment strategies. Scandinavian Journal of Gastroenterology 50:2, pages 233-244.
Read now
Martin Lagging, Ann-Sofi Duberg, Rune Wejstål, Ola Weiland, Magnus Lindh, Soo Aleman & Filip Josephson. (2012) Treatment of hepatitis C virus infection in adults and children: Updated Swedish consensus recommendations. Scandinavian Journal of Infectious Diseases 44:7, pages 502-521.
Read now
Jenny Nilsson & Ola Weiland. (2010) Effect of control selection on sustained viral response rates in genotype 2/3 HCV mono-infected versus HIV/HCV co-infected patients. Scandinavian Journal of Infectious Diseases 42:6-7, pages 533-539.
Read now

Articles from other publishers (14)

Carine Raquel Blatt, Bernd Storb, Nikolai Mühlberger, Mareni Rocha Farias & Uwe Siebert. (2014) Chronic Hepatitis C treatment for genotype 2 or 3 in Brazil: cost effectiveness analysis of peginterferon plus ribavirin as first choice treatment. Brazilian Journal of Pharmaceutical Sciences 50:2, pages 345-352.
Crossref
Monica A. Konerman, Shruti H. Mehta, Catherine G. Sutcliffe, Trang Vu, Yvonne Higgins, Michael S. Torbenson, Richard D. Moore, David L. Thomas & Mark S. Sulkowski. (2014) Fibrosis progression in human immunodeficiency virus/hepatitis C virus coinfected adults: Prospective analysis of 435 liver biopsy pairs. Hepatology 59:3, pages 767-775.
Crossref
J. Stenkvist, A. Sönnerborg & O. Weiland. (2012) HCV RNA decline in chronic HCV genotype 2 and 3 during standard of care treatment according to IL 28B polymorphism . Journal of Viral Hepatitis 20:3, pages 193-199.
Crossref
Dominique Salmon-Ceron, Julien Cohen, Maria Winnock, Perrine Roux, Firouze Bani Sadr, Eric Rosenthal, Isabelle Poizot Martin, Marc-Arthur Loko, Marion Mora, Philippe Sogni, Bruno Spire, François Dabis & Maria Patrizia Carrieri. (2012) Engaging HIV-HCV co-infected patients in HCV treatment: the roles played by the prescribing physician and patients' beliefs (ANRS CO13 HEPAVIH cohort, France). BMC Health Services Research 12:1.
Crossref
M. Ackefors, H. Gjertsen, A. Wernerson & O. Weiland. (2012) Concentration‐guided ribavirin dosing with darbepoetin support and peg‐IFN alfa‐2a for treatment of hepatitis C recurrence after liver transplantation. Journal of Viral Hepatitis 19:9, pages 635-639.
Crossref
Manal Aly Abdel Khalek, Amal Mohamad El-barbary, Ferial Salah Elkalla & Salwa Abdel-Moneim Essa. (2012) Prevalence of peripheral neuropathy in Egyptian hepatitis C virus patients: Correlation to some clinical and laboratory parameters. The Egyptian Rheumatologist 34:3, pages 91-98.
Crossref
Chung-Feng Huang, Jee-Fu Huang, Jeng-Fu Yang, Ming-Yen Hsieh, Zu-Yau Lin, Shinn-Cherng Chen, Liang-Yen Wang, Suh-Hang Hank Juo, Ku-Chung Chen, Wan-Long Chuang, Hsing-Tao Kuo, Chia-Yen Dai & Ming-Lung Yu. (2012) Interleukin-28B genetic variants in identification of hepatitis C virus genotype 1 patients responding to 24 weeks peginterferon/ribavirin. Journal of Hepatology 56:1, pages 34-40.
Crossref
Reiko Etoh, Fumio Imazeki, Tomoko Kurihara, Kenichi Fukai, Keiichi Fujiwara, Makoto Arai, Tatsuo Kanda, Rintaro Mikata, Yutaka Yonemitsu & Osamu Yokosuka. (2011) Pegylated interferon-alfa-2a monotherapy in patients infected with HCV genotype 2 and importance of rapid virological response. BMC Research Notes 4:1.
Crossref
P.-Y. Bochud, S. Bibert, F. Negro, B. Haagmans, A. Soulier, C. Ferrari, G. Missale, S. Zeuzem, J.-M. Pawlotsky, S. Schalm, K. Hellstrand, A.U. Neumann & M. Lagging. (2011) IL28B polymorphisms predict reduction of HCV RNA from the first day of therapy in chronic hepatitis C. Journal of Hepatology 55:5, pages 980-988.
Crossref
Tatsuo Kanda, Fumio Imazeki, Ryosaku Azemoto, Yutaka Yonemitsu, Shigeru Mikami, Kazuhiko Kita, Motohide Takashi, Masahiko Sunaga, Shuang Wu, Shingo Nakamoto, Akinobu Tawada, Makoto Arai, Keizo Kato, Yu Yoshida, Yoshihiro Koma, Keiichi Fujiwara, Kenichi Fukai, Noriaki Suzuki & Osamu Yokosuka. (2011) Response to Peginterferon-alfa 2b and Ribavirin in Japanese Patients with Chronic Hepatitis C Genotype 2. Digestive Diseases and Sciences 56:11, pages 3335-3342.
Crossref
T. Kawaoka, H. Aikata, S. Takaki, A. Hiramatsu, K. Waki, N. Hiraga, D. Miki, M. Tsuge, M. Imamura, Y. Kawakami, S. Takahashi, H. Ochi, H. Tashiro, H. Ohdan & K. Chayama. (2011) IL28B polymorphism may guide pegylated interferon plus ribavirin therapy even after curative treatment for hepatitis C virus-related hepatocellular carcinoma. Journal of Viral Hepatitis 18:10, pages e550-e560.
Crossref
T. Kanda, F. Imazeki, Y. Yonemitsu, S. Mikami, N. Takada, T. Nishino, M. Takashi, A. Tsubota, K. Kato, N. Sugiura, A. Tawada, S. Wu, T. Tanaka, S. Nakamoto, R. Mikata, M. Tada, T. Chiba, T. Kurihara, M. Arai, K. Fujiwara, F. Kanai & O. Yokosuka. (2010) Quantification of hepatitis C virus in patients treated with peginterferon‐alfa 2a plus ribavirin treatment by COBAS TaqMan HCV test. Journal of Viral Hepatitis 18:7.
Crossref
Kevork M. Peltekian, Vincent G. Bain, Samuel S. Lee, Morris Sherman, Curtis L. Cooper, Eric M. Yoshida, Paul J. Marotta, Mel Krajden, Robert Balshaw & Marc Deschênes. (2011) Is pre-treatment liver biopsy necessary for all hepatitis C genotypes?. Annals of Hepatology 10:3, pages 260-269.
Crossref
Martin Lagging, Galia Askarieh, Francesco Negro, Stephanie Bibert, Jonas Söderholm, Johan Westin, Magnus Lindh, Ana Romero, Gabriele Missale, Carlo Ferrari, Avidan U. Neumann, Jean-Michel Pawlotsky, Bart L. Haagmans, Stefan Zeuzem, Pierre-Yves Bochud & Kristoffer Hellstrand. (2011) Response Prediction in Chronic Hepatitis C by Assessment of IP-10 and IL28B-Related Single Nucleotide Polymorphisms. PLoS ONE 6:2, pages e17232.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.